Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinacalcet with Vitamin D in Secondary HPT
NCT00110929Phase 2Completed
- Sponsor
- Amgen
- Start
- Nov 2002
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of cinacalcet in secondary hyperparathyroidism (SHPT), sponsored by Amgen. Started Nov 2002; status: completed.
02
Drugs
cinacalcet
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT00110929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00110929.